Dorcas Ministries provided the BioWork students with a monthly stipend and supported the cohort by hosting biweekly meetings, providing meals and fostering collaboration and mutual support. The ...

A British-Dutch multinational consumer goods company, Reckitt Benckiser, is investing $145.59 million to establish a regional ...

Durham-based Alcami Corp., a contract development and manufacturing organization (CDMO) with a growing presence in North Carolina, has expanded the capabilities of its new pharmaceutical-storage ...

Merz Aesthetics, the largest global dedicated medical aesthetics business, has opened its new Research & Development ...

“Could it be small enough to be flown?” an investor asked out of the audience. “With the proper funding!” responded the entrepreneur on stage, to chuckles and knowing smiles around the auditorium.

In partnership with Duke University, this event will highlight effective strategies to improve diversity in clinical research and celebrate the achievements of individuals actively engaged in these ...

The newly FDA-approved brain cancer therapy Voranigo (vorasidenib) has its roots in North Carolina. It is the product of research by Duke University's Darell Bigner and Bert Vogelstein of Johns ...

Traditional seed breeding methods are slow and expensive, But technology can speed up the process of breeding hardier plants at lower cost, according to Hi Fidelity Genetics, a Durham-based crop ...

Over 30 UNC Chapel Hill core directors and staff will present posters and information about their services and technologies available to customers. This is an opportunity to meet many core directors ...

Bluebird bio, a Massachusetts-based gene and cell therapy company with operations in North Carolina, will sell its Durham biomanufacturing plant to National Resilience for $110 million as part of a ...

Novozymes and Chr. Hansen this week announced their future name: Novonesis. “The name reflects the beginning of an era of biosolutions where Novonesis will unleash the full potential of biological ...

Gov. Roy Cooper announced today that California-based biopharmaceutical company Gilead Sciences, Inc. (Nasdaq; GILD), will invest up to $5 million to establish a 275-employee business services and ...